anticancer
Celltrion’s anti-cancer biosimilars win multiple tenders in Europe – Beragampengetahuan
Celltrion said Thursday that the company’s three oncology biosimilar products — Herzuma, Truxima and Vegzelma — are making their foray into key European markets after winning multiple bids there. Celltrion secured bids in France to supply its cancer-fighting biosimilars to five regional drug purchasing organizations for public hospitals. Both Herzuma and Vegzelma will be supplied […]
SN BioScience released a result of the first clinical trial on Nanoparticle-based anticancer therapy at ESMO(European Society for Medical Oncology) – beragampengetahuan – Beragampengetahuan
SN Bioscience (CEO Park Yung-hwan) released the phase 1 clinical trial result on SNB-101, a new anticancer medicine pipeline, at the ESMO Congress 2023 held in Madrid, Spain, from Oct 20 to 24. The phase 1 clinical trial of 21 patients with solid cancer was conducted to assess the efficacy and safety of the monotherapy […]